Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
UroGen’s Mitomycin: Are Randomized Trials For Bladder Cancer Necessary?
May 19 2025
•
By
Sue Sutter
Is a randomized trial a better fit for some bladder cancers?
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US Advisory Committees
More from Pathways & Standards